HALEON PLC
LSE:HLN

Watchlist Manager
HALEON PLC Logo
HALEON PLC
LSE:HLN
Watchlist
Price: 380.6 GBX -0.13% Market Closed
Market Cap: 34.5B GBX
Have any thoughts about
HALEON PLC?
Write Note

Gross Margin
HALEON PLC

61.9%
Current
62%
Average
31.7%
Industry

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
61.9%
=
Gross Profit
7B
/
Revenue
11.2B

Gross Margin Across Competitors

Country UK
Market Cap 34.7B GBP
Gross Margin
62%
Country JP
Market Cap 121T JPY
Gross Margin
67%
Country FR
Market Cap 181.1B EUR
Gross Margin
74%
Country UK
Market Cap 113.9B GBP
Gross Margin
0%
Country IN
Market Cap 5.5T INR
Gross Margin
52%
Country DE
Market Cap 27.8B EUR
Gross Margin
58%
Country US
Market Cap 26.8B USD
Gross Margin
72%
Country JP
Market Cap 3T JPY
Gross Margin
38%
Country IN
Market Cap 1.1T INR
Gross Margin
56%
Country IN
Market Cap 902.9B INR
Gross Margin
49%
Country US
Market Cap 9.8B USD
Gross Margin
35%
No Stocks Found

HALEON PLC
Glance View

Market Cap
34.8B GBX
Industry
Consumer products

In the bustling world of consumer healthcare, HALEON PLC stands as a luminary figure, emerging with a focused mission: to deliver everyday health with humanity. Spun off from the pharmaceutical giant GlaxoSmithKline, HALEON now charts its independent course, concentrating on the development and distribution of over-the-counter medications, oral health products, and nutritional supplements. Its diverse portfolio includes household names such as Sensodyne, Panadol, and Centrum, demonstrating its wide-reaching impact on consumers’ health routines. These brands are not merely market fixtures; they represent HALEON’s commitment to blending scientific innovation with consumer insights, aiming to enhance well-being across the globe. HALEON’s business model is poised at the intersection of healthcare and retail, thriving through an intricate blend of strategic marketing, global distribution networks, and strong brand equity. By leveraging extensive consumer research data, HALEON aligns its product offerings with the evolving needs and preferences of its audience. The company generates revenue primarily through product sales, employing an omnichannel strategy that ensures product availability across various retail and digital platforms. Its strategic alliances and network with pharmacies, supermarkets, and online marketplaces cement its accessibility and prominence in the market. Additionally, HALEON's stream of revenue is bolstered by its investment in innovation—a key driver that keeps its product lines relevant and competitive in a dynamic healthcare landscape.

HLN Intrinsic Value
334.53 GBX
Overvaluation 12%
Intrinsic Value
Price

See Also

Discover More
What is Gross Margin?

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
61.9%
=
Gross Profit
7B
/
Revenue
11.2B
What is the Gross Margin of HALEON PLC?

Based on HALEON PLC's most recent financial statements, the company has Gross Margin of 61.9%.